New feed
[FrontPageAfrica] Monrovia -Results from PREVAIL I–a large Ebola vaccine study that enrolled more than a thousand Liberians at Redemption Hospital in Monrovia during the first few months of 2015– have been published in the October 12th issue of The New England Journal of Medicine. The results show that the two test vaccines, cAd3-EBOZ and rVSV-ZEBOV, pose no major safety concerns and can produce immune responses within one month after vaccination that last for at least one year.
Source: Liberia: Ebola Test Vaccines Produce Year-Long Immune Response in Most Study Participants

Leave a Reply

Your email address will not be published. Required fields are marked *